✨ Free AI Report
GeneDx Holdings Corp.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview GeneDx Holdings Corp.
Research Preview

GeneDx Holdings Corp.: Business Overview, Financials & Competitive Analysis

GeneDx Holdings is a genomics company providing pediatric and rare disease diagnostics through whole exome and genome sequencing. The company translates complex genomic data into clinical answers that unlock personali...

Analyst-debate audio for GeneDx Holdings Corp.

AskCyborg analysts argue the bull and bear cases for GeneDx Holdings Corp. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
GeneDx Holdings Corp. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
8/ 10Strong

Cyborg Score thesis

Market-leading rare disease genomics platform with accelerating revenue growth, improving profitability, and analyst consensus...

Read the full analyst-debate transcript →
Industry Genomic Diagnostics & Precision Medicine
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest GeneDx Holdings Corp. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

GeneDx Holdings Corp. Overview

Pro stress-test →

GeneDx Holdings is a genomics company providing pediatric and rare disease diagnostics through whole exome and genome sequencing. The company translates complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies.

Strategic Profile

Pro stress-test →

GeneDx is positioned as a leader in advanced exome and genome diagnostics, leveraging its expanding rare disease dataset. The company develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.

Competitive Landscape

Pro stress-test →

GeneDx operates in the $20B+ precision medicine market as a genomics leader. Primary competitors include other clinical genomics labs focused on rare disease diagnostics, variant interpretation, and data analytics. GeneDx differentiates through its large proprietary dataset and AI-driven platform.

Industry Context

GeneDx Holdings Corp. operates in Genomic Diagnostics & Precision Medicine.

Key facts

Founded: 2015 · Headquarters: Stamford, CT · Employees: 1,000 · Revenue: $305.45M (2024)

What the analysts stress-tested

The top findings that survived the multi-agent debate for GeneDx Holdings Corp..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when GeneDx Holdings Corp. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Clinical Exome/Genome SequencingPrenatal and hereditary cancer diagnosticsGenetic Testing ServicesClinical genetic testing and data servicesGenomic Analysis PlatformCancer genomic analysis

Compare GeneDx Holdings Corp. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

GeneDx Holdings Corp. operates in Genomic Diagnostics & Precision Medicine. See how the rest of the sector scores on the Cyborg framework.

Browse Genomic Diagnostics & Precision Medicine research →
NEW · MCP server

Ask your AI assistant about GeneDx Holdings Corp.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare GeneDx Holdings Corp. and its top competitor on Cyborg Score”
“What did GeneDx Holdings Corp. do this quarter?”
“Is GeneDx Holdings Corp. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does GeneDx Holdings Corp. do?+
GeneDx Holdings is a genomics company providing pediatric and rare disease diagnostics through whole exome and genome sequencing. The company translates complex genomic data into clinical answers that unlock personali...
What is GeneDx Holdings Corp.'s Cyborg Score?+
GeneDx Holdings Corp. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are GeneDx Holdings Corp.'s main competitors?+
Named competitors include Clinical Exome/Genome Sequencing, Genetic Testing Services, Genomic Analysis Platform. The full competitive landscape is in the AskCyborg report.
How can I get the full GeneDx Holdings Corp. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the GeneDx Holdings Corp. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track GeneDx Holdings Corp. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual